Filters

A J Scheen
M Moutschen

Showing results (141-150 of 679) with videos related to

Pageof 68
Sort By:
Revue Medicale De Liege|May 27, 2010
[NAVIGATOR: A trial of prevention of cardiovascular complications and type 2 diabetes with valsartan and/or nateglinide]A J Scheen
Revue Medicale De Liege|August 1, 2009
[International classification of various types of monoclonal antibodies]A J Scheen
Revue Medicale De Liege|August 1, 2009
[New advances in therapeutic use of monoclonal antibodies]A J Scheen
Revue Medicale De Liege|August 20, 2015
[PHARMACEUTICAL INDUSTRY AND PERSONALIZED MEDICINE: A PARADIGM SHIFT IN THE DEVELOPMENT OF NEW DRUGS]A J Scheen
Diabetes & Metabolism|February 3, 2020
Reduction in HbA1c with SGLT2 inhibitors vs. DPP-4 inhibitors as add-ons to metformin monotherapy according to baseline HbA1c: A systematic review of randomized controlled trialsA J Scheen
Revue Medicale De Liege|January 14, 2021
[Which place to be reserved to sulphonylureas and which precautions to be taken ?]A J Scheen
Diabetes & Metabolism|August 22, 2018
Cardiovascular safety of DPP-4 inhibitors compared with sulphonylureas: Results of randomized controlled trials and observational studiesA J Scheen
Revue Medicale De Liege|June 18, 2019
[Alcohol and car driving]A J Scheen
Revue Medicale De Liege|June 18, 2019
[Alcohol, protective or risk factor for cardiovascular disease ?]A J Scheen
Revue Medicale De Liege|March 24, 2015
[How I treat...Recommendations when starting a pharmacological therapy]A J Scheen
Pageof 68

Showing results (141-150 of 679) with videos related to

Sort By:
Pageof 68
Revue Medicale De Liege|May 27, 2010
[NAVIGATOR: A trial of prevention of cardiovascular complications and type 2 diabetes with valsartan and/or nateglinide]A J Scheen
Revue Medicale De Liege|August 1, 2009
[International classification of various types of monoclonal antibodies]A J Scheen
Revue Medicale De Liege|August 1, 2009
[New advances in therapeutic use of monoclonal antibodies]A J Scheen
Revue Medicale De Liege|August 20, 2015
[PHARMACEUTICAL INDUSTRY AND PERSONALIZED MEDICINE: A PARADIGM SHIFT IN THE DEVELOPMENT OF NEW DRUGS]A J Scheen
Diabetes & Metabolism|February 3, 2020
Reduction in HbA1c with SGLT2 inhibitors vs. DPP-4 inhibitors as add-ons to metformin monotherapy according to baseline HbA1c: A systematic review of randomized controlled trialsA J Scheen
Revue Medicale De Liege|January 14, 2021
[Which place to be reserved to sulphonylureas and which precautions to be taken ?]A J Scheen
Diabetes & Metabolism|August 22, 2018
Cardiovascular safety of DPP-4 inhibitors compared with sulphonylureas: Results of randomized controlled trials and observational studiesA J Scheen
Revue Medicale De Liege|June 18, 2019
[Alcohol and car driving]A J Scheen
Revue Medicale De Liege|June 18, 2019
[Alcohol, protective or risk factor for cardiovascular disease ?]A J Scheen
Revue Medicale De Liege|March 24, 2015
[How I treat...Recommendations when starting a pharmacological therapy]A J Scheen
Pageof 68
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us